Organisation paid for research Program year 2021 Source: CMS Open Payments

3A Research LLC

Neither a doctor nor a teaching hospital

Research payments

$219,694

17 payments

Through program year 2021, 3A Research LLC is reported as receiving $219,694 in research payments, across 17 payments.

By program year

1 row

Year	Kind	Amount	Payments
2021	Research	$219,694	17

Breakdown

Who paid Research payments · program year 2021

Taro Pharmaceuticals USA, Inc. $219,694 17 payments

Studies the money was for Research payments · program year 2021

A Study Comparing Tretinoin Gel Microsphere, 0.1 and RETIN-A MICRO Gel Microsphere, 0.1 in the Treatment of Acne Vulgaris $107,478 6 payments
A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis. $47,575 4 payments
Study $28,530 4 payments
A Multi-center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, Comparing TRETINOIN 0.025 (Taro Pharmaceuticals U.S.A) and RETIN-A (Tretinoin) Cream 0.025 and Both Active Treatment to a Placebo Control in the Treatment of Acne Vulgaris $28,111 2 payments
A Phase II, Randomized, Double Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo $8,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.